Pease5,6 | BM | SG | 8 | 3.6% | 7 NHL, not specified; 2 multiple myelomas | 4% | 221 HL and NHL |
Kim7 | LNs | SG | | | 1 nodular mixed histiocytic–lymphocytic lymphoma; 2 histiocytic lymphomas | 3.5% | 84 untreated NHL CLL, and Mb; Waldenström excluded |
Sacks3 | BM, LNs | SG | 17 | 2.8% | | | 608 HL |
O’Carroll8 | BM | SG | 6 | 5.6% | | | 107 HL |
Yu9 | BM | SG | | | 1 nodular poorly differentiated lymphoma; 2 diffuse poorly differentiated lymphomas; 4 diffuse histiocytic lymphomas; 1 diffuse mixed histiocytic–lymphocytic lymphoma; 1 unclassified splenic lymphoma | | 9 cases observed |
Choe10 | BM | SG | | | 3 poorly differentiated lymphocytic lymphomas; 3 histiocytic lymphomas; 3 MMs; 1 acute lymphoplastic leukaemia | 2.6% | 372 NHL |
Bhargava13 | BM | SG | 7 | 0.1% of all biopsies | 8 NHL, not specified; 1 acute lymphoblastic leukaemia; 1 CLL 1 MM | 0.16% of all biopsies | 6988 bone marrow biopsies; 72 specimens with granulomas |
Spier11 | LNs | SG | | | 11 “Lennert” lymphomas of B and T cell origin | 3.1% | 355 NHL |
Hollingsworth2 | BM | Clusters of histiocytes | | | 5 Burkitt lymphomas; 2 follicular lymphomas | | 7 cases observed |
Dunphy4 | LNs | SG | | | 1 immunocytoma | | Single case observed |
Kornacker1 | BM | SG | | | 1 diffuse large B cell lymphoma | | Single case observed |
Blanco14 | LNs | NG | | | 3 CLL | | 3 cases observed |
Haralambieva12 | LNs | SG | | | 4 Burkitt lymphomas | 6% | 67 Burkitt lymphomas |